Relenza (Zanamivir) Clinical Study Reports

Full set of clinical study reports for the neuraminidase inhibitor Relenza (Zanamivir) produced by GlaxoSmithKline and made available to the Cochrane collaboration for the production of their meta-analysis of neuraminidase inhibitors for preventing and treating influenza in healthy adults and children